DaHui Lawyers has extensive experience in capital markets transactions and has served as PRC counsel for issuers and underwriters in both equity and debt offerings in the US and Hong Kong, handling IPOs, secondary offerings, bond offerings and private placements. Managing partner of DaHui Lawyers, Richard Ma, has more than 20 years of experience in representing companies in capital markets, M&A, investments and compliance matters. His industry strengths are in media and entertainment, and technology and telecommunications. The firm welcomed corporate lawyers Jacky Zhu, Yingyuan Xue and Pei Zhao, alongside IP lawyers Li Xiang and Jieyun Cai who joined from Fangda Partners during the research period.
Represented CICC Capital and Goldstone New Materials Fund, as lead investors, in their pre-IPO investment in Jiangsu Tiangong Tools, one of the global leading manufacturers of high-speed steel and die steel.
Represented BioMind in its series A+ round financing.
Represented Sinopharm-CICC Healthcare Investment Fund as co-investor in the series C2 financing of Ribo Life Science, an innovative drug research and development company.
Anji Pharma, GSR Ventures, Hillhouse Capital, Merck Ventures, Viva Biotech
Represented Hengtian Mingze Fund Sales in defending a lawsuit brought by an investor, concerning the loss the investor sustained in a high-risk investment. The firm obtained a court judgment in favour of its broker client.
Represented China Securities in an unprecedented litigation regarding false statements of an underwriter. This is the first known case where the underwriting of an inter-bank bond is being sued for false statements in China.
Represented private equity investor Xinyu Zhentou in a litigation against the controller of an invested company over redemption rights.
Burton, Chenco Holdings, Hengqin Dingxin Xingtie Investment Management Enterprise
Acted for JHD, a retail and financial technology services provider, on its merger with East Stone Acquisition Corporation, a publicly traded special purpose acquisition company.
Represented American venture capital firm Sequoia Capital in the establishment of a joint venture with GitLab, a web-based DevOps lifecycle tool. This is a market-entry joint venture for GitLab and a significant venture in China for Sequoia.
Acted for American multinational technology company Nvidia as antitrust trustee in its acquisition of Mellanox, an Israeli-American multinational supplier of computer networking products.
Represented Coca Cola and Mengniu on the merger control filing for the establishment of their joint venture in China.
Acted for Finnish company Cargotec as antitrust trustee in its acquisition of TTS Group.
Advised Elsevier, a Netherlands-based publishing company specialising in scientific, technical, and medical content, on regulatory matters related to its market entry, cooperation, and business growth in China.
Acted for CBS on regulatory matters in relation to its sale of entity with rare operating licenses.
Cloudflare, Comcast, Netflix